Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Mass Drug Administration (MDA) for Lymphatic Filariasis Elimination in Uttar Pradesh, India: Issues, Gaps & Challenges

Kamal S, Chandra R, Singh SM, et al. Journal of Communicable Diseases. 2020; 52 (3) : 62-73.
Download PDF
Publication

Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring & evaluating (M&E) programmes post the cessation of mass drug administration (MDA).

Collyer B, Irvine M, Hollingsworth DT, et al. PLoS neglected tropical diseases. 2020; 14 (10) : e0008644.
Download PDF
Publication

NTDs in the time of COVID-19.

Adepoju P. The Lancet. Microbe. 2020; 1 (6) : e244.
Download PDF
Publication

Interventions for the management of snakebite envenoming: An overview of systematic reviews.

Bhaumik S, Beri D, Lassi Z, et al. PLoS neglected tropical diseases. 2020; 14 (10) : e0008727.
Download PDF
Publication

Assessing Evaluation of eHealth Interventions in Uganda: Practices, Challenges and Insights

Ashaba J, Nabukenya J. Journal of Health Informatics in Africa. 2020; 7 (1) : 12-23.
Download PDF
Publication

Measurement of Quality of Life in patients of Leprosy attending Outdoor Patient Department at Tertiary Care Center of Ahmedabad: A Cross Sectional Study

Solanki SD, Barot JP, Patel JH, et al. Indian journal of leprosy. 2020;
Download PDF
Publication

Parents’ attitude towards their children and adolescents affected by leprosy in an endemic district in West Bengal, India

Darlong J, Govindharaj P. Lepra. Leprosy review. 2020; 91 (3) : 282-290.
Download PDF
Publication

The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis

Schoenmakers A, Mieras L, Budiawan T, et al. Informa UK Limited. Research and Reports in Tropical Medicine. 2020;
Download PDF
Publication

Global prevalence of intestinal parasitic infections and associated risk factors in pregnant women: a systematic review and meta-analysis

Taghipour A, Ghodsian S, Jabbari M, et al. Oxford University Press (OUP). Transactions of The Royal Society of Tropical Medicine and Hygiene. 2020;
Publication

COVID-19 in LMICs: The Need to Place Stigma Front and Centre to its Response

Roelen K, Ackley C, Boyce P, et al. The European Journal of Development Research. 2020;
Download PDF

Pagination

  • Previous page ‹ ‹ Previous
  • …
  • Page 460
  • Page 461
  • Page 462
  • Page 463
  • Current page 464
  • Page 465
  • Page 466
  • Page 467
  • Page 468
  • …
  • Next page Next › ›
  • Last page Last » »
Subscribe to

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2025 InfoNTD